Evidence map›Paper›PMID 34776968›Full record

ReviewFrontiers in pharmacology2021

The Impact of Inflammatory Immune Reactions of the Vascular Niche on Organ Fibrosis.

Hong-Yan Zhou, Hua Sui, Yang-Jianing Zhao, Hong-Jie Qian, Nan Yang, Lu Liu, Qing Guan, Yue Zhou, Hong-Li Lin, Da-Peng Wang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hong-Yan ZhouThe First Affiliated Hospital, Dalian Medical University, Dalian, China.
Hua SuiInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Yang-Jianing ZhaoInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Hong-Jie QianInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Nan YangInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Lu LiuInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Qing GuanInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Yue ZhouDepartment of Nephrology, The First Affiliated Hospital, Dalian Medical University, Dalian, China.
Hong-Li LinInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Da-Peng WangInstitude college of Integrative Medicine, Dalian Medical University, Dalian, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a type of defense response against tissue damage, and can be mediated by lymphocytes and macrophages. Fibrosis is induced by tissue injury and inflammation, which leads to an increase in fibrous connective tissue in organs and a decrease in organ parenchyma cells, finally leading to organ dysfunction or even failure. The vascular niche is composed of endothelial cells, pericytes, macrophages, and hematopoietic stem cells. It forms a guiding microenvironment for the behavior of adjacent cells, and mainly exists in the microcirculation, including capillaries. When an organ is damaged, the vascular niche regulates inflammation and affects the repair of organ damage in a variety of ways, such as via its angiocrine function and transformation of myofibroblasts. In this paper, the main roles of vascular niche in the process of organ fibrosis and its mechanism of promoting the progress of fibrosis through inflammatory immunoregulation are summarized. It was proposed that the vascular niche should be regarded as a new therapeutic target for organ fibrosis, suggesting that antifibrotic effects could be achieved by regulating macrophages, inhibiting endothelial-mesenchymal transition, interfering with the angiocrine function of endothelial cells, and inhibiting the transformation of pericytes into myofibroblasts, thus providing new ideas for antifibrosis drug research.

Indexed as

antifibrosisendothelial cellsfibrosisinflammationmacrophagespericytesvascular niche

Identifiers

PMID34776968
PMCPMC8585779
OpenAlexW3208609721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.